You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EZH2 GoF

Showing 51 - 75 of 100
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma Trial (Bendamustine, Rituximab, Tazemetostat)

Not yet recruiting
  • Follicular Lymphoma
  • (no location specified)
Dec 15, 2022

Advanced Solid Tumors Trial in Grand Rapids, Houston, San Antonio (CPI-1205, ipilimumab)

Completed
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +2 more
May 16, 2022

Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

Not yet recruiting
  • Sinonasal Cancer
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 5, 2023

Next Generation Sequencing in Familial Acute Myeloid Leukemia

Recruiting
  • Leukemia
  • Analysis with molecular biology
  • Brescia, Italy
    Chair of Hematology and Bone marrow Transplant Unit
Apr 21, 2022

Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Platinum-Resistant Lung Small Cell Carcinoma

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +3 more
  • Biopsy
  • +4 more
  • Los Angeles, California
  • +8 more
Jan 31, 2023

Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Duarte (Tazemetostat, Ublituximab, Umbralisib)

Not yet recruiting
  • Recurrent Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Duarte, California
    City of Hope Medical Center
Jul 31, 2022

Early Development of Endometrial Carcinoma

Recruiting
  • Cancer of Endometrium
    • Ferrara, Italy
      Section of Obstetrics and Gynecology, Department of Morphology,
    Apr 4, 2022

    Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)

    Recruiting
    • Metastatic Prostate Cancer
    • Metastatic Castration-resistant Prostate Cancer
    • Boston, Massachusetts
    • +1 more
    Jul 18, 2022

    MDS Trial in Innsbruck (Next Generation Sequencing, Tumorimmunological examinations - multiplex assays/quantitative polymerase

    Recruiting
    • Myelodysplastic Syndromes
    • Next Generation Sequencing
    • +5 more
    • Innsbruck, Tyrol, Austria
      Medical University of Innsbruck
    Apr 6, 2022

    All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,

    Active, not recruiting
    • All Malignancies
    • +11 more
    • Encinitas, California
    • +9 more
    May 20, 2022

    Acute Myeloid Leukemia Trial in Heidelberg (Bortezomib, Gemtuzumab Ozogamicin)

    Recruiting
    • Acute Myeloid Leukemia
    • Heidelberg, Baden-Württemberg, Germany
      University Hospital Heidelberg, Internal Medicine V
    May 25, 2020

    Gastric and Cardia Adenocarcinomas Trial in Strasbourg (Biopsy)

    Recruiting
    • Gastric and Cardia Adenocarcinomas
    • Biopsy
    • Strasbourg, France
      University Hospital, Strasbourg, france
    Aug 31, 2021

    Advanced Soft Tissue Sarcoma, Advanced Epithelioid Sarcoma Trial in Worldwide (Tazemetostat, Placebo, Doxorubicin HCl)

    Recruiting
    • Advanced Soft Tissue Sarcoma
    • Advanced Epithelioid Sarcoma
    • Duarte, California
    • +20 more
    Jan 31, 2022

    Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

    Recruiting
    • Atypical Teratoid Rhabdoid Tumor
    • +6 more
    • Boston, Massachusetts
    • +1 more
    Jan 23, 2023

    Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL), Castration Resistant Prostate Cancer (CRPC) Trial in Russian

    Recruiting
    • Small Cell Lung Cancer (SCLC)
    • +2 more
    • Tucson, Arizona
    • +62 more
    Jan 18, 2023

    Acute Myeloid Leukemia Trial in France (Cytarabine and Idarubicin, CPX-315)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Amiens, France
    • +29 more
    Apr 8, 2022

    Cancer, Tumors Trial in France, United Kingdom, United States (GSK2816126)

    Terminated
    Has Results
    • Cancer
    • Neoplasms
    • Chicago, Illinois
    • +4 more
    Feb 17, 2020

    MDS Patients Using Sequential Peripheral Blood Samples

    Recruiting
    • Myelodysplastic Syndromes
      • Badalona, Barcelona, Spain
        Josep Carreras Leukaemia Research Institute
      Mar 8, 2022

      Myeloproliferative Tumors Trial in Taoyuan

      Enrolling by invitation
      • Myeloproliferative Neoplasms
        • Taoyuan, State, Taiwan
          Chang Gung Memorial Hospital-Linkou
        Aug 4, 2021

        Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)

        Terminated
        • Leukemia, Myeloid, Acute
        • Leukemia, Lymphocytic, Acute
        • Boston, Massachusetts
        • +5 more
        Jun 11, 2021

        Molecular Diagnostic Platform for AML

        Recruiting
        • Acute Myeloid Leukemia (AML)
          • Córdoba, Spain
          • +6 more
          Sep 3, 2021

          Personalizing Colorectal Cancer Medicine (ImmuCol2)

          Active, not recruiting
          • Colon Cancer
            • Besançon, France
            • +8 more
            Oct 11, 2021

            MDS Trial in Hong Kong

            Recruiting
            • Myelodysplastic Syndromes
              • Hong Kong, Hong Kong
                Department of Medicine, the University of Hong Kong, Queen Mary
              Nov 3, 2020

              Hepatic Impairment Trial in Miami, Orlando, San Antonio (DS-3201b)

              Completed
              • Hepatic Impairment
              • Miami, Florida
              • +2 more
              Feb 24, 2021

              Lymphoma, DLBCL, Follicular Lymphoma Trial in Belgium, France (Tazemetostat, Rituximab, Cyclophosphamide)

              Recruiting
              • Lymphoma
              • +2 more
              • Bruxelles, Belgium
              • +30 more
              Jul 23, 2021